When Chevrolet decided it was time to replace the OBS with an all-new model at the end of the 1990s, it was facing a tough ...
Jay Bradner, president of the Novartis Institutes for Biomedical Research (NIBR), is retiring from the position after seven years in the role, and will be replaced by Merck & Co R&D executive Fiona ...